Agilent Technologies
About: Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Employees: 17,900
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
102% more call options, than puts
Call options by funds: $229M | Put options by funds: $113M
2.51% more ownership
Funds ownership: 87.15% [Q1] → 89.66% (+2.51%) [Q2]
3% more capital invested
Capital invested by funds: $29B [Q1] → $29.9B (+$926M) [Q2]
3% more first-time investments, than exits
New positions opened: 117 | Existing positions closed: 114
0% more funds holding in top 10
Funds holding in top 10: 9 [Q1] → 9 (+0) [Q2]
4% less repeat investments, than reductions
Existing positions increased: 354 | Existing positions reduced: 367
1% less funds holding
Funds holding: 1,009 [Q1] → 995 (-14) [Q2]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
|
Wells Fargo
Brandon Couillard
|
$150
|
Overweight
Maintained
|
15 Sep 2025 |
|
Barclays
Luke Sergott
|
$125
|
Equal-Weight
Maintained
|
29 Aug 2025 |
|
Baird
Catherine Schulte
|
$142
|
Outperform
Maintained
|
28 Aug 2025 |
|
Evercore ISI Group
Vijay Kumar
|
$128
|
In-Line
Maintained
|
28 Aug 2025 |
Financial journalist opinion
Based on 20 articles about A published over the past 30 days
